MICHAEL DENNIS PRICE Insider Trading $NOVN NOVEN PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL DENNIS PRICE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL DENNIS PRICE. MICHAEL DENNIS PRICE is VP and Chief Financial Officer in NOVEN PHARMACEUTICALS INC ($NOVN).
MICHAEL DENNIS PRICE in NOVEN PHARMACEUTICALS INC
Trading Symbol: NOVNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL DENNIS PRICE: VP and Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 27 2009
$NOVN Market Capitalization: $65.66M
$NOVN Previous Close: $4.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL DENNIS PRICE in NOVEN PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Option Exercise | D | 11.09 | 66,921 | 742,154 | 0 | |
Aug 27 2009 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Option Exercise | D | 13.93 | 62,500 | 870,625 | 0 | |
Aug 21 2009 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Sell | U | 16.50 | 25,000 | 412,500 | 0 | 25 K to 0 (-100.00 %) |
Nov 25 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.45 | 2,500 | 23,625 | 25,000 | 22.5 K to 25 K (+11.11 %) |
Nov 25 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.41 | 4,281 | 40,284 | 22,500 | 18.2 K to 22.5 K (+23.50 %) |
Nov 25 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.29 | 3,219 | 29,905 | 18,219 | 15 K to 18.2 K (+21.46 %) |
Nov 20 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Option Exercise | A | 11.09 | 66,922 | 742,165 | 66,922 | |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.78 | 44 | 430 | 15,000 | 15 K to 15 K (+0.29 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.79 | 1,956 | 19,149 | 14,956 | 13 K to 15 K (+15.05 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.80 | 4,500 | 44,100 | 13,000 | 8.5 K to 13 K (+52.94 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.81 | 3,100 | 30,411 | 8,500 | 5.4 K to 8.5 K (+57.41 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.84 | 100 | 984 | 5,400 | 5.3 K to 5.4 K (+1.89 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.86 | 100 | 986 | 5,300 | 5.2 K to 5.3 K (+1.92 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.87 | 1,000 | 9,870 | 5,200 | 4.2 K to 5.2 K (+23.81 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.89 | 894 | 8,842 | 4,200 | 3.3 K to 4.2 K (+27.04 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.90 | 1,406 | 13,919 | 3,306 | 1.9 K to 3.3 K (+74.00 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.91 | 100 | 991 | 1,900 | 1.8 K to 1.9 K (+5.56 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.92 | 300 | 2,976 | 1,800 | 1.5 K to 1.8 K (+20.00 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.98 | 1,500 | 14,970 | 1,500 | 0 to 1.5 K |
Nov 20 2007 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Option Exercise | A | 13.93 | 62,500 | 870,625 | 62,500 |
Page: 1